Delivery Order SPE2DR25D3301-SPE2DR26F17ZZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,117.35 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract was awarded on August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial medication will support federal medical supply requirements, likely for military personnel...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,268.08 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100-count package) on August 6, 2025, with completion targeted for August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,469.83 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atovaquone-Proguanil 250-100mg in 100-count units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication delivery supports federal medical procurement requirements, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $38,258.58 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets in a quantity of 100 units. This competitively awarded, firm fixed-price contract with no set-aside designation was issued on November 13, 2025, with an ultimate completion date of November 14, 2025. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an...
- The Defense Logistics Agency awarded a delivery order valued at $22,857.87 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This competitive, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 21, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. The medication is an...
- The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be...
- The Defense Logistics Agency (DLA) awarded a $1,426.28 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S tablets on October 22, 2025, with completion expected by October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's broader relationship with DLA. The order is being fulfilled from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,119.30 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial pharmaceutical is being procured through the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Atovaquone-Proguanil 250-100 mg tablets in quantities of 100 units, with a contract ceiling value of $27,644.83. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by November 10, 2025, and will be performed at the contractor's Corporate Office...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F17ZZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,044.48 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Atovaquone-Proguanil 250-100mg tablets (100 count). This firm fixed-price delivery order is non-set-aside and scheduled for ultimate completion by November 14, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication will support military and federal healthcare requirements through the agency's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of pharmaceutical products and medical supplies supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's demonstrated capability to fulfill competitive federal procurements across diverse therapeutic domains and order values positions it as a key provider within the Defense Logistics Agency's pharmaceutical supply network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 11/13/25 |